Levitra like its rival drugs Viagra and Cialis is a PDE 5 inhibitor

Some good news for the manufacturers of the erectile dysfunction medication Levitra is that a clinical trial that looked at the drug saw that it could be extremely effective in helping men who suffer from the impotence condition due to high cholesterol levels.

High cholesterol is one of the major causes of bad erectile function and can lead to the condition known as dyslipidemia. This in turn can aggravate arteriosclerosis which is the condition that causes hardening of the arteries. Since good blood flow is essential for good erectile function men suffering from arterial problems will almost certainly have impaired sexual function.

Levitra like its rival drugs Viagra and Cialis is a PDE 5 inhibitor which means that it will help to open up the penile artery and facilitate healthy blood flow to the penis. This study evaluated the effect of the Levitra drug on men with high cholesterol and was done using a placebo controlled and double blind methodology. This study is the first one to evaluate the effectiveness and safety of the Levitra drug specifically in men suffering from dyslipidemia and erectile dysfunction.

It is estimated that around three quarters of men who suffer from erectile dysfunction also suffer from either hypertension, dyslipidemia, high cholesterol or diabetes. Levitra has the lowest sales figures out of the three erectile dysfunction drugs on the market today however this does not mean that it is less effective than the other two. In independent testing it has been shown to be just as effective as Viagra and Cialis and some men prefer it and say it works better for them than the other two.

Levitra is manufactured in Europe by the German drug company Bayer Pharmaceuticals and its active ingredient is called vardenafil.